Mitchell Pamela J, Johnson Sally E, Hannon Kevin
Department of Basic Medical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, Indiana 47907, USA.
Dev Dyn. 2002 Jan;223(1):12-23. doi: 10.1002/dvdy.1227.
Insulin-like growth factor I (IGF-I) is expressed in the anterior and posterior mesodermal cells of the developing limb. However, a definite role for IGF-I during early limb organogenesis is unknown. To determine the inherent participation of IGF-I during limb organ development, a retroviral delivery system (RCAS) was used to overexpress IGF-I throughout the developing hind limb of stage 24 chicken embryos. The area of the belly of the external gastrocnemius muscle in the IGF-I infected limb was an average of 160, 90, 70, and 80% larger than the contralateral control muscle belly, 4, 5, 6, and 7 days postinjection, respectively (all differences P < 0.01). In comparison to the contralateral control muscles, there were a significantly greater number of muscle fibers in the IGF-I infected muscles (P < 0.05), confirming that the majority of IGF-I-mediated muscle enlargement was due to an increase in total fiber numbers (hyperplasia). Four days postinjection, there was a 32% increase in myoblast to myofiber ratio in the muscle of injected limbs compared with the muscle in the contralateral noninjected control limbs (P < 0.05). This result demonstrates that IGF-I acts to expand the undifferentiated myoblast population, and as a result, more myofibers subsequently develop, and the muscles expressing ectopic IGF-I are enlarged by means of hyperplasia. There was no difference in tibiotarsus and fibula length or diameter between the IGF-I injected and control limb, suggesting that ectopic IGF-I expression within the mesoderm was not a nonspecific growth stimulant of all tissues of the developing limb, but specifically enhanced skeletal muscle development and growth. Ectopic IGF-I expression had no significant effect on myostatin mRNA concentrations. Our results support a model where mesodermally expressed IGF-I acts to regulate the number of primary myofibers, and, therefore, size of skeletal muscles, which form during the initial events of limb myogenesis.
胰岛素样生长因子I(IGF-I)在发育中肢体的前后中胚层细胞中表达。然而,IGF-I在早期肢体器官发生过程中的明确作用尚不清楚。为了确定IGF-I在肢体器官发育中的内在作用,使用逆转录病毒递送系统(RCAS)在第24阶段鸡胚的整个发育后肢中过表达IGF-I。注射后4、5、6和7天,IGF-I感染肢体的腓肠肌肌腹面积分别比同侧对照肌腹平均大160%、90%、70%和80%(所有差异P<0.01)。与同侧对照肌肉相比,IGF-I感染肌肉中的肌纤维数量明显更多(P<0.05),证实IGF-I介导的肌肉增大主要是由于总纤维数量增加(增生)。注射后4天,与对侧未注射对照肢体的肌肉相比,注射肢体肌肉中的成肌细胞与肌纤维比例增加了32%(P<0.05)。这一结果表明,IGF-I的作用是扩大未分化的成肌细胞群体,结果是随后形成更多的肌纤维,并且通过增生使表达异位IGF-I的肌肉增大。IGF-I注射肢体和对照肢体的胫跗骨和腓骨长度或直径没有差异,表明中胚层内异位IGF-I的表达不是发育中肢体所有组织的非特异性生长刺激物,而是特异性地促进骨骼肌的发育和生长。异位IGF-I表达对肌肉生长抑制素mRNA浓度没有显著影响。我们的结果支持这样一种模型,即中胚层表达的IGF-I作用于调节初级肌纤维的数量,从而调节在肢体肌生成初始事件中形成的骨骼肌的大小。